A study published this week in Nature sheds new light on the connection between the gut and the brain, untangling the complex interplay that allows the byproducts of microorganisms living in the gut to influence the progression ...
May 16, 2018
0
5518
Multiple sclerosis, which affects one in 1,000 people, is frequently characterised by relapses associated with variable functional impairments including among others vision problems, impairment of locomotor functions or difficulties ...
May 16, 2018
0
133
A study led by the University of Birmingham has found that analysis of fluid in the spine could be used to predict the future progression of multiple sclerosis.
May 9, 2018
0
106
A new study identifies a molecule that may be critical to the repair of white matter, the fatty tissue wrapped around parts of brain cells that helps speed up communication. Damage to white matter is associated with several ...
May 7, 2018
0
16
Among predictions of a second fracking boom in the US, the first evidence that chemicals found in ground water near fracking sites can impair the immune system will be published in Toxicological Sciences on May 1. The study, ...
May 1, 2018
0
15
Researchers from the Saint Louis University School of Medicine have discovered why many multiple myeloma patients experience severe pain when treated with the anticancer drug bortezomib. The study, which will be published ...
Apr 27, 2018
0
133
For most people, it's better to start taking drugs for multiple sclerosis (MS) early on rather than letting the disease run its course, according to a new guideline for treating MS from the American Academy of Neurology. ...
Apr 23, 2018
0
6
A study published in the current issue of Psychotherapy and Psychosomatics indicates that psychotherapy may improve psychological distress and help coping with multiple sclerosis. Psychosocial interventions are often used ...
Apr 19, 2018
0
17
A compound derived from immune cells treats psoriasis in mice and holds promise for other autoimmune diseases, according to a new study from Washington University School of Medicine in St. Louis.
Apr 18, 2018
0
888
(HealthDay)—For patients with secondary progressive multiple sclerosis, the selective sphingosine 1-phosphate (S1P) receptor1,5 modulator, siponimod, is associated with reduced relative risk of confirmed disability progression, ...
Mar 23, 2018
0
11
